Docket Number:10A-1040212
Inventor:Jyh-Yih Chen, Chang-Jer Wu
IP Status:TW I617317、CN 106039284 B、US pending
Abstract:
Helicobacter pylori (H. pylori), which has been associated with gastritis and duodenal ulears, commonly chronically infects adults. The common treatment of H. pylori infection includes antibiotics and a combination of a proton pump inhibitor. However, there are several problems with these therapies, such as side effects related to the use of a high dose of antibiotics and the emergence of resistant strains of H. pylori. Therefore, applying of antimicrobial peptides to develop of a prophylactic or therapeutic agent may be an attractive strategy against H. pylori infection.
Fields of Application:
TP4 may be an effective prophylactic or therapeutic agents for H. pylori infection.
Advantages when compared to the existing technologies:
Antimicrobial peptides have broad spectrum antibacterial activity in organisms. They are not affected by traditional antibiotic resistance mutant strains and do not easily produce drug-resistant strains. It may be an effective prophylactic or therapeutic agents for H. pylori infection.
Contact Person:
對本技術有興趣,請於本處網頁廠商選項下(廠商需求與諮詢)網頁填寫資料,承辦人將跟您聯絡。
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Apply for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office, and the undertaker will contact you.
